Dr. Brian P. Gladnick, MD

Dr. Gladnick practices at Texas Health Dallas in Dallas, Texas, part of Texas Health Resources.

Dr. Gladnick's NPI, 1184949505, was assigned on March 29, 2010. Dr. Gladnick graduated from Weill Cornell Medicine in 2010. Dr. Gladnick holds Texas license R9066.

Dr. Gladnick's primary practice is Texas Health Dallas, at 8200 Walnut Hill Lane, Dallas, TX 75231 in Dallas County. The practice phone is (214) 345-6789.

Dr. Gladnick's primary practice is Texas Health Dallas in Dallas, Texas, part of Texas Health Resources. Dr. Gladnick is also affiliated with Baylor Scott & White Institute for Rehabilitation - Dallas. The medical group on file is OrthoLoneStar. Dmand AI also links Dr. Gladnick to 4 more hospitals and 1 home health agency, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Gladnick practices, 7 sites in all. Vendor and product names are available with a free account.

Orthopaedic surgery is Dr. Gladnick's primary specialty in the NPI Registry, under taxonomy code 207X00000X. Dr. Gladnick is board certified in orthopaedic surgery by the American Board of Orthopaedic Surgery. Dmand AI has Dr. Gladnick's licenses on file in 6 states: Texas, District of Columbia, Maryland, Virginia, North Carolina and New York.

Dmand AI lists arthritis, bursitis, fluid in a joint, hip replacement, joint arthropathy, joint pain, knee injury and knee replacement among the conditions Dr. Gladnick treats.

CMS data shows 3,316 Medicare services from Dr. Gladnick across 21 procedure codes in 2024, for 880 Medicare patients. Medicare paid $377,969 for them.

CMS counts 880 Medicare patients who saw Dr. Gladnick in 2024. The largest group is 65 to 74, with 478 patients. 75% of them have arthritis, and 75% have high cholesterol. Their average risk score is 0.81, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Gladnick's median patient age at 70, with 60% women.

In 2024, Dr. Gladnick wrote 1,368 Medicare Part D claims for 486 patients. 99% of them were for generic drugs. CMS names the drug for 1,297 of them, across 12 drugs with 11 or more claims each, at $7,236 in total drug cost. In 2023, CMS named 1,197 claims across 15 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Gladnick for performance year 2024, reported individually. Dr. Gladnick accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 138 procedures of hip replacement by Dr. Gladnick, more than 99% of the clinicians it reports for that procedure.

Dmand AI links 57 papers to Dr. Gladnick, published from 2011 to 2025. 2020 was the busiest year, with 6. The most frequent topics are Arthroplasty, Replacement, Hip, Arthroplasty, Replacement, Knee and Hip Prosthesis. Dr. Gladnick has published most often in J Arthroplasty. Dr. Gladnick's most frequent co-authors are Kurt J. Kitziger, MD, Paul C. Peters, MD and David W. Romness, MD.

CMS Open Payments shows 241 general payments to Dr. Gladnick from 23 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 81% of the total. Medical Device Business Services, Inc. paid the most, $74,276.

Dr. Gladnick graduated from Weill Cornell Medicine in 2010.

Dr. Gladnick is in network with 23 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 15. Check the plan with the practice before a visit.